CurrentRheuma
Get Weekly

CurrentRheuma coverage · page 27 of 48

Rheumatology (Oxford)

Briefs 1,041–1,080 of 1,905 CurrentRheuma has covered from this journal, newest publication first

Latest from Rheumatology (Oxford)

All coverage, newest first

  1. Rheumatology (Oxford)

    Serum interleukin-34 levels in dermatomyositis: a potential biomarker for anti-MDA5-antibody-associated interstitial lung disease

    Cross-sectional studyMyositis

  2. Rheumatology (Oxford)

    Comparison of rituximab efficacy in treatment-naïve and refractory inflammatory myopathies: experiences from a tertiary care centre

    Cohort studyMyositis

  3. Rheumatology (Oxford)

    Exploring relief for Behçet’s disease refractory oral ulcers: a comparison of TNF inhibitors versus apremilast

    Cohort studyVasculitis & PMR

  4. Rheumatology (Oxford)

    Familial Mediterranean fever in patients with inflammatory bowel diseases: a nationwide study from the epi-IIRN

    Cohort studyAutoinflammatory & rare

  5. Rheumatology (Oxford)

    Anti-HMGCR myopathy: estimated five-fold higher incidence in Polynesian compared with European populations in Aotearoa/New Zealand

    Cohort studyMyositis

  6. Rheumatology (Oxford)

    Ex vivo cell-based assay for assessment of response to TNF inhibitors in patients with rheumatic diseases

    Diagnostic or prognostic studyAcross diseases

  7. Rheumatology (Oxford)

    Extracorporeal membrane oxygenation for acute lung injury in idiopathic inflammatory myopathies—a potential lifesaving intervention

    Cohort studyMyositis

  8. Rheumatology (Oxford)

    Ramosetron as an add-on therapy for refractory fibromyalgia: a randomized, double-blind, placebo-controlled trial

    Randomized controlled trialFibromyalgia & pain

  9. Rheumatology (Oxford)

    Modifiable risk factors and inflammation-related proteins in polymyalgia rheumatica: genome-wide meta-analysis and Mendelian randomization

    Meta-analysisVasculitis & PMR

  10. Rheumatology (Oxford)

    Combination of scavenger receptor-A with anti-cyclic citrullinated peptide antibody for the diagnosis of rheumatoid arthritis

    Diagnostic or prognostic studyRA

  11. Rheumatology (Oxford)

    Polyarticular juvenile idiopathic arthritis has a distinct co-inhibitor receptor profile

    Mechanistic studyPediatric

  12. Rheumatology (Oxford)

    Prospective assessment of glucocorticoid toxicity in rheumatology practice: a focus on the glucocorticoid toxicity index

    Cohort studyVasculitis & PMR

  13. Rheumatology (Oxford)

    Treatment of psoriasis with different classes of biologics reduces the likelihood of peripheral and axial psoriatic arthritis development

    Cross-sectional studySpondyloarthritis & PsA

  14. Rheumatology (Oxford)

    B cell depletion after treatment with rituximab predicts relapse of IgG4-related disease

    Cohort studyAutoinflammatory & rare

  15. Rheumatology (Oxford)

    Efficacy and safety of biologic drugs in Still's disease: a systematic review and network meta-analysis of randomized controlled trials

    Meta-analysisAutoinflammatory & rare

  16. Rheumatology (Oxford)

    Disruption of memory B-cell trafficking by belimumab in patients with systemic lupus erythematosus

    Mechanistic studyLupus & APS

  17. Rheumatology (Oxford)

    Description of the characteristics of the nailfold capillary structure in healthy children: a multi-centric study

    Cross-sectional studyPediatric

  18. Rheumatology (Oxford)

    Systemic sclerosis sine scleroderma is more aggressive in children than in adults

    Cohort studyPediatric

  19. Rheumatology (Oxford)

    Low-density granulocytes and neutrophil extracellular trap formation are increased in incomplete systemic lupus erythematosus

    Cross-sectional studyLupus & APS

  20. Rheumatology (Oxford)

    Serum proteomic profiles of patients with chronic recurrent multifocal osteomyelitis

    Mechanistic studyAutoinflammatory & rare

  21. Rheumatology (Oxford)

    Transorbital ultrasound in the diagnosis of giant cell arteritis

    Diagnostic or prognostic studyVasculitis & PMR

  22. Rheumatology (Oxford)

    Native myocardial T1 and right ventricular size by CMR predict outcome in systemic sclerosis-associated pulmonary hypertension

    Cohort studySystemic sclerosis

  23. Rheumatology (Oxford)

    Distinct features of ANCA-associated hypertrophic pachymeningitis compared with other etiologies: findings from a study of 74 patients

    Cohort studyVasculitis & PMR

  24. Rheumatology (Oxford)

    Identification and characteristics of patients with potential difficult-to-treat psoriatic arthritis: exploratory analyses of the Greek PsA registry

    Cross-sectional studySpondyloarthritis & PsA

  25. Rheumatology (Oxford)

    The influence of the cardiac cycle on the halo sign and its impact on the ultrasound diagnosis of giant cell arteritis

    Cross-sectional studyVasculitis & PMR

  26. Rheumatology (Oxford)

    Effect of bimekizumab on patient-reported disease impact in patients with psoriatic arthritis: 1-year results from two phase 3 studies

    Secondary analysisSpondyloarthritis & PsA

  27. Rheumatology (Oxford)

    Potential impact of European Medicines Agency measures to minimize risk of serious side effects on JAKi prescribing and utilization in the UK

    Cohort studyRA

  28. Rheumatology (Oxford)

    Can we predict kidney involvement in patients with systemic lupus erythematosus? A retrospective cohort study with independent validation

    Cohort studyLupus & APS

  29. Rheumatology (Oxford)

    Rituximab retention rate in systemic sclerosis: a long term real-life multicentre study

    Cohort studySystemic sclerosis

  30. Rheumatology (Oxford)

    Erosive progression by high-resolution peripheral quantitative computed tomography and conventional radiography in rheumatoid arthritis

    Diagnostic or prognostic studyRA

  31. Rheumatology (Oxford)

    Psychological distress over 12 months post-diagnosis in an early inflammatory arthritis cohort

    Cohort studyRA

  32. Rheumatology (Oxford)

    Can the dose of belimumab be reduced in patients with systemic lupus erythematosus?

    Cohort studyLupus & APS

  33. Rheumatology (Oxford)

    Validation of the Behçet’s Syndrome Overall Damage Index (BODI) for retrospective studies and a proposal for modification

    Diagnostic or prognostic studyVasculitis & PMR

  34. Rheumatology (Oxford)

    Risk of urolithiasis associated with allopurinol versus benzbromarone among patients with gout: a population-based cohort study

    Cohort studyGout & crystals

  35. Rheumatology (Oxford)

    Optimal exposure of mycophenolic acid for induction therapy of childhood lupus nephritis patients: an observational cohort study

    Cohort studyPediatric

  36. Rheumatology (Oxford)

    Arthritis in patients with very early systemic sclerosis: a comprehensive clinical and prognostic analysis

    Cohort studySystemic sclerosis

  37. Rheumatology (Oxford)

    Predictive factors and treatment outcomes associated with difficult-to-treat rheumatoid arthritis conditions: the ANSWER cohort study

    Cohort studyRA

  38. Rheumatology (Oxford)

    The OMERACT giant cell arteritis ultrasonography score: a potential predictive outcome for assessing the risk of relapse during follow-up

    Cohort studyVasculitis & PMR

  39. Rheumatology (Oxford)

    Glymphatic abnormality in systemic lupus erythematosus detected by diffusion tensor image analysis along the perivascular space

    Cross-sectional studyLupus & APS

  40. Rheumatology (Oxford)

    A treatment algorithm for familial Mediterranean fever patients with menstruation-associated attacks

    Cross-sectional studyPediatric

All 1,905 Briefs in ExploreShowing Briefs 1,041–1,080 of 1,905, newest first